A Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of LiuWei DiHuang Pill in Treating Type 2 Diabetes Mellitus [Corrigendum]

Abstract

He D, Huang JH, Zhang ZY, et al. Drug Des Devel Ther. 2019;13:3989–4005.The authors missed to mention equal contribution of the authors Dan He and Jian Hua Huang in the author list. The revised author list should appear as follows:Dan He,1,* Jian-Hua Huang,1– 3,* Zhe-Yu Zhang,4 Qing Du,1 Wei-Jun Peng,4 Rong Yu,1,2 Si-Fang Zhang,4 Shui-Han Zhang,1 Yu-Hui Qin1  1Hunan Academy of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan 410013, People’s Republic of China; 2Hunan Key Laboratory of TCM Prescription and Syndromes Translational Medicine, Changsha, Hunan 410208, People’s Republic of China; 32011 Collaboration and Innovation Center for Digital Chinese Medicine in Hunan, Changsha 410013, People’s Republic of China; 4Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, People’s Republic of China*These authors contributed equally to this workRead the original article

Keywords

• lwdh pill
• type 2 diabetes mellitus (t2dm)
• network pharmacology